A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel. [electronic resource]
Producer: 20170110Description: 189-200 p. digitalISSN:- 1873-4995
- ATP Binding Cassette Transporter, Subfamily B -- antagonists & inhibitors
- Administration, Oral
- Animals
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Breast Neoplasms -- drug therapy
- Cell Survival -- drug effects
- Delayed-Action Preparations
- Dose-Response Relationship, Drug
- Drug Carriers
- Drug Combinations
- Drug Compounding
- Drug Synergism
- Female
- G2 Phase Cell Cycle Checkpoints -- drug effects
- Humans
- Hydrogels
- Injections, Intralesional
- Injections, Intravenous
- Lapatinib
- MCF-7 Cells
- Mice, Inbred BALB C
- Mice, Nude
- Nanoparticles
- Nanotechnology
- Paclitaxel -- administration & dosage
- Poloxamer -- chemistry
- Protein Kinase Inhibitors -- administration & dosage
- Quinazolines -- administration & dosage
- Receptor, ErbB-2 -- antagonists & inhibitors
- Solubility
- Technology, Pharmaceutical -- methods
- Temperature
- Time Factors
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.